spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online January 12, 2004
Journal of Experimental Biology 207, 571-578 (2004)
Published by The Company of Biologists 2004
doi: 10.1242/jeb.00495
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerencser, G. A.
Right arrow Articles by Ahearn, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerencser, G. A.
Right arrow Articles by Ahearn, G. A.

Electrogenic proton-regulated oxalate/chloride exchange by lobster hepatopancreatic brush-border membrane vesicles

George A. Gerencser1,*, Frank Robbins2, Jianliang Zhang2 and Gregory A. Ahearn3

1 Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL 32610, USA
2 Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
3 Department of Biology, College of Arts & Sciences, University of North Florida, Jacksonville, FL 32224, USA



View larger version (18K):

[in a new window]
 
Fig. 1. Time course of 0.1 mmol l–1 [14C]oxalate uptake by hepatopancreatic brush-border membrane vesicles (BBMV). Vesicles contained 100 mmol l–1 TMA-gluconate and 50 mmol l–1 K-gluconate ({blacksquare}, {square}) or 100 mmol l–1 TMA-gluconate, 25 mmol l–1 K-gluconate and 25 mmol l–1 KHCO3 (•). Incubation media contained 100 mmol l–1 TMA-gluconate and 50 mmol l–1 K-gluconate ({square}, •) or 100 mmol l–1 Na-gluconate and 50 mmol l–1 K-gluconate ({blacksquare}). All media contained 40 mmol l–1 Hepes-Tris and 50 µmol l–1 valinomycin at pH 7.0.

 


View larger version (11K):

[in a new window]
 
Fig. 2. Effect of the chloride channel inhibitor 9-carboxyanthracene (9-AC) on [14C]oxalate uptake into hepatopancreatic BBMV. Vesicular and incubation media contained 100 mmol l–1 TMA-gluconate, 100 mmol l–1 K-gluconate and 50 µmol l–1 valinomycin, with (test) or without (control) 50 µmol l–1 9-AC.

 


View larger version (14K):

[in a new window]
 
Fig. 3. Time course of 0.1 mmol l–1 [14C]oxalate uptake by hepatopancreatic BBMV. Vesicles were preloaded with 100 mmol l–1 TMA-gluconate, 25 mmol l–1 K-gluconate, 25 mmol l–1 KCl and 50 µmol l–1 valinomycin ({blacksquare}), 150 mmol l–1 TMA-gluconate and 50 mmol l–1 µmol l–1 CCCP ({square}) or 100 mmol l–1 TMA-gluconate, 50 mmol l–1 K-gluconate and 50 µmol l–1 valinomycin (•). Incubation media contained 100 mmol l–1 TMA-gluconate and 50 mmol l–1 K-gluconate ({blacksquare}, •) or 100 mmol l–1 K-gluconate and 50 mmol l–1 TMA-gluconate ({square}). All media contained 40 mmol l–1 Hepes-Tris at pH 7.0.

 


View larger version (19K):

[in a new window]
 
Fig. 4. Effect of membrane potential on the uptake of 0.1 mmol l–1 [14C]oxalate uptake into hepatopancreatic BBMV. Vesicles were preloaded with 100 mmol l–1 TMA-gluconate and 100 mmol l–1 TMA-Cl ({blacksquare}) or 100 mmol l–1 K-gluconate and 100 mmol l–1 TMACl ({square}, •). Incubation media contained 100 mmol l–1 K-gluconate and 100 mmol l–1 TMA-gluconate ({blacksquare}, {square}) or 200 mmol l–1 TMA-gluconate (•). All media contained 40 mmol l–1 Hepes-Tris and 50 µmol l–1 valinomycin at pH 7.0.

 


View larger version (15K):

[in a new window]
 
Fig. 5. Effect of internal organic anions on 0.1 mmol l–1 [14C]oxalate uptake into hepatopancreatic BBMV. Vesicles were loaded with 100 mmol l–1 TMA-gluconate, 100 mmol l–1 K-gluconate and 5 mmol l–1 of the indicated anion (substituted iso-osmotically for TMA). Incubation media contained 100 mmol l–1 TMA-gluconate, 100 mmol l–1 K-gluconate and 0.1 mmol l–1 [14C]oxalate. All media contained 40 mmol l–1 Hepes-Tris and 50 µmol l–1 valinomycin at pH 7.0. Control anion, gluconate.

 


View larger version (21K):

[in a new window]
 
Fig. 6. Influence of internal pH on the uptake of 0.1 mmol l–1 [14C]oxalate into hepatopancreatic BBMV. Vesicles contained 100 mmol l–1 TMA-Cl, 50 mmol l–1 K-gluconate, 50 µmol l–1 valinomycin and pH adjusted to 7.0 ({square}) or 8.0 ({blacksquare}) with 40 mmol l–1 Hepes-Tris, or pH 5.0 ({circ}) or 6.0 (•) with 40 mmol l–1 Mes-Tris. Incubation media contained 100 mmol l–1 TMA-gluconate, 50 mmol l–1 K-gluconate and 40 mmol l–1 Hepes-Tris at pH 7.0.

 


View larger version (20K):

[in a new window]
 
Fig. 7. Influence of external pH on the uptake of 0.1 mmol l–1 [14C]oxalate into hepatopancreatic BBMV. Vesicles contained 100 mmol l–1 TMA-Cl, 50 mmol l–1 K-gluconate, 50 µmol l–1 valinomycin and 40 mmol l–1 Hepes-Tris at pH 7.0. Incubation media contained 100 mmol l–1 TMA-gluconate and 50 mmol l–1 K-gluconate, and pH was adjusted to 7.0 (•) or 8.0 ({circ}) with Hepes-Tris, or pH 5.0 ({blacksquare}) or 6.0 ({square}) with Mes-Tris.

 


View larger version (19K):

[in a new window]
 
Fig. 8. Effect of various bilateral pH conditions on the uptake of 0.1 mmol l–1 [14C]oxalate into hepatopancreatic BBMV. Vesicles contained 100 mmol l–1 TMA-Cl, 50 mmol l–1 K-gluconate, 50 µmol l–1 valinomycin and adjusted to pH 7.0 (•) or 8.0 ({circ}) with 40 mmol l–1 Hepes-Tris, or to pH 5.0 ({blacksquare}) or 6.0 ({square}) with 40 mmol l–1 Mes-Tris. Incubation media contained 100 mmol l–1 TMA-gluconate and 50 mmol l–1 K-gluconate with pH adjusted as above.

 


View larger version (28K):

[in a new window]
 
Fig. 9. Effect of inside-negative vesicular interior on (A) [14C]oxalate/Cl exchange and (B) 36Cl/Ox2– exchange in hepatopancreatic BBMV. (A) Vesicles were preloaded with 100 mmol l–1 KCl and 100 mmol l–1 TMA-gluconate and incubated in media containing 0.1 mmol l–1 [14C]oxalate and either 100 mmol l–1 K-gluconate and 100 mmol l–1 TMA-gluconate (open bar) or 200 mmol l–1 TMA-gluconate (hatched bar). (B) Vesicles were preloaded with 50 mmol l–1 K2SO4 and 75 mmol l–1 TMA-gluconate and incubated in media containing 10 mmol l–1 36Cl and either 100 mmol l–1 K-gluconate and 100 mmol l–1 TMA-gluconate (open bar) or 200 mmol l–1 TMA-gluconate (hatched bar). All media contained 40 mmol l–1 Hepes-Tris at pH 7.0.

 


View larger version (16K):

[in a new window]
 
Fig. 10. Effect of potential inhibitors on [14C]Ox2–/Cl exchange in hepatopancreatic BBMV. Vesicles were preloaded with 100 mmol l–1 TMA-gluconate, 100 mmol l–1 KCl and 50 µmol l–1 valinomycin. Incubation media contained 0.1 mmol l–1 [14C]oxalate, 100 mmol l–1 TMA-gluconate, 100 mmol l–1 K-gluconate and either 1 mmol l–1 SITS, DIDS, bumetanide or furosemide. Control incubation media contained 190 mmol l–1 TMA-gluconate and 100 mmol l–1 K-gluconate. All media contained 40 mmol l–1 Hepes-Tris at pH 7.0.

 


View larger version (19K):

[in a new window]
 
Fig. 11. Effect of external Ox2– concentration on the uptake of 0.1 mmol l–1 [14C]Ox2– into hepatopancreatic BBMV. Vesicles were preloaded with 100 mmol l–1 TMA-Cl, 50 mmol l–1 K-gluconate and 50 µmol l–1 valinomycin. Incubation media contained 100 mmol l–1 TMA-gluconate, 50 mmol l–1 K-gluconate and indicated oxalate concentrations. All media contained 40 mmol l–1 Hepes-Tris at pH 7.0.

 





© The Company of Biologists Ltd 2004